EU Watch: Three Cosmetics-Relevant Areas Targeted For Imminent Policy Development
This article was originally published in The Rose Sheet
Executive Summary
The European Commission is committed to completing its review “shortly” of the Cosmetics Regulation in light of endocrine disruptor criteria recently implemented in other sectors. Cosmetics industry stakeholders should also keep an eye out for developments as the Commission evolves its approach to nanomaterials and microplastics.
You may also be interested in...
ECHA: Hundreds Of Nanomaterials May Be On European Market Illegally
Just 36 of an expected 300 substances used in nanoforms have been registered under REACH, as required by the start of 2020, according to the European Chemicals Agency, which is focused on driving compliance. Meanwhile, the Scientific Committee on Consumer Safety has accepted a Commission request that could lead to priority assessments of cosmetic nanomaterials and restrictions on the use of others.
Global Corporate Insurer Projects Increased Liability For ‘Toxic Trio’ Use In Cosmetics
Allianz Global Corporate and Specialty raises liability concerns that could be relevant to cosmetics manufacturers still using “toxic trio” ingredients. The firm’s report is a signal at least that rampant US litigation for alleged false advertising and undeclared ingredient risks has reached the international insurance consciousness.
EU Watch: Next Steps Re Controversial CMR Ban Approach, Fragrance Allergens Labeling
EU sources update Rose Sheet on contentious initiatives to cement the Commission’s pathway for banning carcinogenic, mutagenic or reprotoxic substances in cosmetics and to promote fragrance allergen awareness and risk management.